TTAX01

BIOLOGICAL4 trials

Sponsors

BioTissue Holdings, Inc

Conditions

Diabetic Foot InfectionNon-healing Diabetic Foot UlcerNon-healing WoundVenous Leg Ulcer

Phase 2

Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)

CompletedNCT03230175

BioTissue Holdings, IncDiabetic Foot Infection, Non-healing Diabetic Foot Ulcer, Non-healing Wound

Start: 2017-10-04End: 2019-04-01Updated: 2021-06-15

Subjects With Non-Healing Venous Leg Ulcers Treated With Standard Care Plus Cryopreserved Human Umbilical Cord (TTAX01)

CompletedNCT03818828

BioTissue Holdings, IncVenous Leg Ulcer

Start: 2019-02-14End: 2020-01-28Updated: 2020-09-03

Phase 3

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

CompletedNCT04176120

BioTissue Holdings, IncDiabetic Foot Infection, Non-healing Diabetic Foot Ulcer, Non-healing Wound

Start: 2020-07-01End: 2024-06-12Updated: 2024-06-14

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)

CompletedNCT04450693

BioTissue Holdings, IncDiabetic Foot Infection, Non-healing Diabetic Foot Ulcer, Non-healing Wound

Start: 2020-11-20End: 2025-03-24Updated: 2025-04-01